Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 inVentiv Health To Acquire Kforce Clinical Research | Contract Pharma

What are you searching for?

Sign in
Breaking News

inVentiv Health To Acquire Kforce Clinical Research

Will join functional service provider and staffing businesses

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

inVentiv Health, Inc. has signed a definitive agreement to acquire Kforce Clinical Research, Inc. (KCR) for $50 million in cash. KCR will be combined with inVentiv’s existing functional service provider (FSP) and staffing businesses within the clinical segment. The transaction is expected to close at the end of March 2012.

KCR’s clinical services include: site management and monitoring, clinical project and program management, clinical programming and data management, biostatistical analysis and reporting, pharmacovigilance, medical writing, regulatory affairs, and quality assurance and training.

“With its strong clinical monitoring expertise, a customer-focused approach and an impressive portfolio of clients, Kforce Clinical Research is an attractive complement to inVentiv’s existing services. This acquisition expands our capability across the continuum of FSP, staffing and CRO services, further enhancing our ability to deliver flexible, cost-effective solutions for our clients,” said Paul Meister, chief executive officer of inVentiv Health.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics